Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 (PROACC-1)
Non-small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer
About this trial
This is an interventional treatment trial for Non-small Cell Lung Cancer focused on measuring cancer, anorexia, cachexia, weight loss, loss of appetite, fatigue
Eligibility Criteria
Key Inclusion Criteria:
- Documented diagnosis of non-small cell lung, pancreatic, colorectal cancer
- Cachexia defined by Fearon criteria
- Serum GDF-15 concentrations
- Signed informed consent
Key Exclusion Criteria:
- Receiving tube feedings or parenteral nutrition at the time of Screening or Randomization.
- Current active reversible causes of decreased food intake.
- Cachexia caused by other reasons.
- History of allergic or anaphylactic reaction to any therapeutic or diagnostic monoclonal antibody.
- inadequate renal or liver function
Sites / Locations
- CARTI ConwayRecruiting
- CARTI Cancer CenterRecruiting
- CARTI North Little RockRecruiting
- CARTI StuttgartRecruiting
- Pacific Cancer Medical Center INCRecruiting
- Beverly Hills Cancer CenterRecruiting
- Emad Ibrahim,MD,INC.Recruiting
- Providence Medical FoundationRecruiting
- Christiana Care Health Services - Helen F. Graham Cancer CenterRecruiting
- Christiana Care Health Services, Helen F. Graham Cancer Center PharmacyRecruiting
- Christiana Care Hematology Oncology - Helen F Graham Cancer CenterRecruiting
- Medical Oncology Hematology Consultants, P A, Helen F. Graham Cancer CenterRecruiting
- Christiana Care Health Services - Christiana HospitalRecruiting
- Tallahassee Memorial HealthCareRecruiting
- TMH Cancer CenterRecruiting
- IU Health Arnett Cancer CenterRecruiting
- Baptist Health LexingtonRecruiting
- Pennington Biomedical Research CenterRecruiting
- Tandem Clinical Research
- Tandem Clinical ResearchRecruiting
- Bozeman Health Deaconess HospitalRecruiting
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Fremont
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Regional
- Oncology Hematology West P.C. dba Nebraska Cancer - Methodist
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists
- Oncology Hematology West P.C. dba Nebraska Cancer - Papillion
- Regional Cancer Care Associates
- Duke Cancer InstituteRecruiting
- Marion L. Shepard Cancer CenterRecruiting
- Oregon Health and Science University: Center for Health and Healing 1Recruiting
- Oregon Health and Science University: Center for Health and Healing 2Recruiting
- Oregon Health and Science UniversityRecruiting
- The University of Texas MD Anderson Cancer CenterRecruiting
- Carta - Clinical Associates in Research Therapeutics of America, LLCRecruiting
- Peninsula Cancer InstituteRecruiting
- Virginia Mason Medical CenterRecruiting
- VA Puget Sound Health Care SystemRecruiting
- Medical Oncology Associates, PS (dba Summit Cancer Centers)Recruiting
- Medical Oncology Associates, PS (dba Summit Cancer Centers)Recruiting
- Medical Oncology Associates, PSRecruiting
- Central Washington Health Services Association d/b/a Confluence Health
- Wenatchee Valley HospitalRecruiting
- St Vincent's Hospital SydneyRecruiting
- Orange HospitalRecruiting
- Prince of Wales HospitalRecruiting
- GenesisCare North Shore
- GenesisCare North ShoreRecruiting
- St Vincent's Hospital MelbourneRecruiting
- Peter MacCallum Cancer CentreRecruiting
- Western Health-Sunshine & Footscray HospitalsRecruiting
- Complex Oncology Center - BurgasRecruiting
- Specialized Hospital for Active Treatment of Oncology - HaskovoRecruiting
- "University Multiprofile Hospital for Active Treatment - Dr. Georgi Stranski" EADRecruiting
- Complex Oncology Center - Ruse EOODRecruiting
- Complex Oncology Center - ShumenRecruiting
- Multiprofile Hospital for Active Treatment Serdika EOODRecruiting
- MHAT for Women's Health NadezhdaRecruiting
- University Specialized Hospital for Active Treatment of Oncology EADRecruiting
- University Multiprofile Hospital for Active Treatment SofiamedRecruiting
- Complex Oncology Center - VratsaRecruiting
- William Osler Health SystemRecruiting
- Victoria Hospital & Children's Hospital - London Health Sciences CentreRecruiting
- The Ottawa Hospital - General CampusRecruiting
- Princess Margaret Cancer CentreRecruiting
- CIUSSS- saguenay-Lac-Saint-Jean
- CIUSSS- saguenay-Lac-Saint-JeanRecruiting
- Centre Hospitalier Regional De RimouskiRecruiting
- Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de RimousRecruiting
- Peking University First HospitalRecruiting
- Henan Cancer HospitalRecruiting
- Tongji Hospital Tongji Medical,Science & TechnologyRecruiting
- Changzhou No.2 People's HospitalRecruiting
- Changzhou No.2 People's HospitalRecruiting
- Changzhou No.2 People's HospitalRecruiting
- The First Affiliated Hospital of Nanchang UniversityRecruiting
- Qilu Hospital of Shandong UniversityRecruiting
- Shanghai Changhai HospitalRecruiting
- Shanxi Provincial Cancer HospitalRecruiting
- Sir Run Run Shaw Hospital of Zhejiang University School of MedicineRecruiting
- The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical UniversityRecruiting
- Fakultni nemocnice Olomouc
- Fakultni nemocnice Bulovka
- Res Medica s.r.o.
- Oblastní nemocnice Příbram, a.s.
- Bacs-Kiskun Varmegyei Oktatokorhaz
- Jász-Nagykun-Szolnok Megyei Hetényi Géza KórházRecruiting
- Semmelweis Egyetem
- Országos Korányi Pulmonológiai IntézetRecruiting
- National Cancer Center Hospital EastRecruiting
- National Hospital Organization Shikoku Cancer CenterRecruiting
- Hyogo Cancer CenterRecruiting
- Kanagawa cancer centerRecruiting
- Aichi Cancer Center HospitalRecruiting
- Shizuoka Cancer CenterRecruiting
- Japanese Foundation For Cancer Research Cancer Institute HospitalRecruiting
- University Hospital,Kyoto Prefectural University of Medicine
- University Hospital,Kyoto Prefectural University of MedicineRecruiting
- Japanese Foundation for Cancer ResearchRecruiting
- Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o.Recruiting
- Szpital Specjalistyczny im. Ludwika Rydygiera w KrakowieRecruiting
- Wojewodzki Szpital Specjalistyczny w Bialej PodlaskiejRecruiting
- Szpital Specjalistyczny w Prabutach Spolka z o.o.Recruiting
- Regionalny Szpital Specjalistyczny im. dr. Władyslawa BiegańskiegoRecruiting
- NZOZ "Vegamed"Recruiting
- Specjalistyczna Praktyka Lekarska Slawomir MandziukRecruiting
- Centrum Pulmonologii i Torakochirurgii w Bystrej
- Fakultna nemocnica s poliklinikou F. D. Roosevelta Banska BystricaRecruiting
- Univerzitna nemocnica Bratislava, Nemocnica Ruzinov
- Narodny onkologicky ustav, II. Onkologicka klinika LFUK a NOURecruiting
- Specializovana nemocnica sv. Svorada Zobor, n.o.Recruiting
- Fakultna nemocnica s poliklinikou Nove ZamkyRecruiting
- Nemocnica na okraji mesta, n.o.Recruiting
- Fakultna nemocnica TrnavaRecruiting
- Hospital Universitari Vall d'HebronRecruiting
- Hospital Universitari General de CatalunyaRecruiting
- Institut Català d'Oncologia - L'HospitaletRecruiting
- Hospital Son LlàtzerRecruiting
- Fundación Instituto Valenciano de OncologíaRecruiting
- Hospital Universitario HM SanchinarroRecruiting
- Hospital Universitari i Politecnic La FeRecruiting
- Chi Mei Hospital - Liouying BranchRecruiting
- Kaohsiung Medical University Chung-Ho Memorial HospitalRecruiting
- China Medical University HospitalRecruiting
- National Cheng Kung University HospitalRecruiting
- Koo Foundation Sun Yat-Sen Cancer CenterRecruiting
- Chang Gung Medical Foundation-Linkou BranchRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Placebo Comparator
Experimental
Experimental
Double-Blind ponsegromab Treatment low dose followed by Open Label ponsegromab Treatment
Double-Blind Placebo Treatment followed by Open-Label ponsegromab Treatment
Double-Blind ponsegromab Treatment medium dose followed by Open Label ponsegromab Treatment
Double-Blind ponsegromab Treatment high dose followed by Open Label ponsegromab Treatment
ponsegromab low dose subcutaneous injection every 4 weeks
Match placebo subcutaneous injection every 4 weeks
ponsegromab medium dose subcutaneous injection every 4 weeks
ponsegromab high dose subcutaneous injection every 4 weeks